MonitorDirect · GrowthWatch before adding
UTI Nifty Alpha Low-Volatility 30 Index Fund
UTI Mutual FundIndex Funds - Equity Funds1.9 years
The scheme seeks to provide returns that, before expenses, corresponds to the total return of the securities as represented by the underlying index, subject to tracking error.
- NAV
- 9.0986
- 29 Oct 2026
- 1Y
- -8.3%
- Trailing CAGR
- AUM
- ₹63.43 Cr
- 30 Sept 2026
- Volatility
- Medium
- 12.8% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return (Sharpe) is negative over the available daily history.
Prefer peers if · Prefer Aditya Birla Sun Life BSE 500 Quality 50 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
1.9 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.79% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -16.6%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Lokesh Kulthia · 0.4 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 39.2% of the portfolio.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-8.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI-6.0%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-9.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- -6.0%
- Calendar-day CAGR
- Excess 1Y
- -1.9%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -16.6%
- Worst peak-to-trough
- Current
- -11.7%
- Below last peak
- Current spell
- 692 days
- Days below latest peak
- Time below peak
- +99%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 1 days
- 1 recovered episodes
- Longest recovery
- 1 days
- Trough to prior peak
6 Dec 2024 – open
Trough 28 Feb 2025 · not recovered
-16.6%
3 Dec 2024 – 5 Dec 2024
Trough 4 Dec 2024 · recovered in 1 days
-0.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
4
Vs category
38
Consistency
7
Risk-adjusted
0
Drawdown
59
Mean
22
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Risk-adjusted return (Sharpe) is negative over the available daily history.
Supporting reads
No supporting reads in the current evidence set.
Portfolio
30 Sept 2026 · 31 holdings · top 10 are 39.2%.
- Top 5
- 20.7%
- Top 10
- 39.2%
- Largest holding
- 4.7%
- Effective holdings
- 29.4
Torrent Pharmaceuticals Ltd
Healthcare
4.7%
NTPC Ltd
Energy & Utilities
4.1%
Bajaj Auto Ltd
Consumer Discretionary
4.0%
Marico Ltd
Consumer Staples
4.0%
Apollo Hospitals Enterprise Ltd
Healthcare
3.9%
What changed
DECISION
Status moved from REVIEW to MONITOR.
15 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Aditya Birla Sun Life BSE 500 Quality 50 Index Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- -3.9%
- 3Y
- n/a
- Vol
- 13.6%
- Max DD
- -11.4%
- Sharpe
- -0.31
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Groww Nifty Next 50 Index Fund
Groww Mutual Fund
- 1Y
- -2.5%
- 3Y
- n/a
- Vol
- 16.6%
- Max DD
- -14.3%
- Sharpe
- -0.14
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
JioBlackRock Nifty Midcap 150 Index Fund
Jio BlackRock Mutual Fund
- 1Y
- -3.9%
- 3Y
- n/a
- Vol
- 15.9%
- Max DD
- -14.0%
- Sharpe
- -0.33
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Aditya Birla Sun Life Nifty 50 Equal Weight index Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- -6.1%
- 3Y
- +11.1%
- Vol
- 13.7%
- Max DD
- -18.0%
- Sharpe
- 0.45
- 3Y win
- +28%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Aditya Birla Sun Life Nifty Midcap 150 Index Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- -4.0%
- 3Y
- +13.8%
- Vol
- 16.7%
- Max DD
- -21.2%
- Sharpe
- 0.69
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown